GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · Daily pill from Eli Lilly leads to 15% weight loss in midstage study, rivaling Wegovy results without the shot. These drugs mimic gut hormones to curb appetite and slow stomach emptying, and are...
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
Nov 8, 2023 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
Daily pill cuts body weight by up to 13% after 3 months in ... - NBC News
Sep 10, 2024 · A daily weight loss pill from Novo Nordisk was shown to lower body weight by up to 13% after three months in a Phase 1 clinical trial, according to findings presented Tuesday at the...
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial - Forbes
Sep 11, 2024 · Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more rapid weight loss than its popular obesity injection Wegovy...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
Nov 9, 2023 · A new weight loss drug has been approved that promises to be the most effective medication yet. Zepbound belongs to a new class of medications, alongside Ozempic and Wegovy, that have...
An oral weight loss pill has just passed early trials with promising ...
Sep 26, 2024 · Amycretin is a new drug that targets two incretin hormone receptors: GLP-1 and amylin. It can lead to up to 13% weight loss in overweight or obese people in 12 weeks, according to early trials.
FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPR
Nov 8, 2023 · Darron Cummings/AP. An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy. Eli...